CE vs EYPT · rev $10.28B vs rev $43.3M
Celanese Corporation (CE) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported EYPT revenue for 2024-12-31 was $43.3M. Net income was -$130.9M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. EYPT currently screens at market cap $1.10B.
CE currently screens at market cap $5.92B. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the CE and EYPT stock pages for the full models.
Not investment advice.